Remifentanil Fresenius Kabi 5 mg inj./inf. sol. (pwdr., conc.) i.v. vial
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Remifentanil Hydrochloride 5,5 mg - Eq. Remifentanil 5 mg
Available from:
Fresenius Kabi SA-NV
ATC code:
N01AH06
INN (International Name):
Remifentanil Hydrochloride
Dosage:
5 mg
Pharmaceutical form:
Powder for concentrate for solution for injection/infusion
Composition:
Remifentanil Hydrochloride 5.5 mg
Administration route:
Intravenous use
Therapeutic area:
Remifentanil
Product summary:
CTI code: 356343-01 - Pack size: 5 mg - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 356343-02 - Pack size: 5 x 5 mg - Commercialisation status: NO - Delivery mode: Medical prescription
Authorization status:
Commercialised: No
Authorization date:
2009-12-15
